[go: up one dir, main page]

NO980566L - Allergen-XCD32 fusion proteins - Google Patents

Allergen-XCD32 fusion proteins

Info

Publication number
NO980566L
NO980566L NO980566A NO980566A NO980566L NO 980566 L NO980566 L NO 980566L NO 980566 A NO980566 A NO 980566A NO 980566 A NO980566 A NO 980566A NO 980566 L NO980566 L NO 980566L
Authority
NO
Norway
Prior art keywords
fusion proteins
xcd32
allergen
fcyrii
antigens
Prior art date
Application number
NO980566A
Other languages
Norwegian (no)
Other versions
NO980566D0 (en
Inventor
Geert C Mudde
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO980566L publication Critical patent/NO980566L/en
Publication of NO980566D0 publication Critical patent/NO980566D0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Insects & Arthropods (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Fusjonsproteiner omfattende en eller flere antigener og en eller flere deler som reagerer med human Fcy-reseptor II (FcyRII) (CD32).Fusion proteins comprising one or more antigens and one or more moieties that react with human Fcy receptor II (FcyRII) (CD32).

NO980566A 1995-08-16 1998-02-10 Allergen-XCD32 fusion proteins NO980566D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9516760.7A GB9516760D0 (en) 1995-08-16 1995-08-16 Organic compounds
PCT/EP1996/003616 WO1997007218A1 (en) 1995-08-16 1996-08-16 Allergen-xcd32 fusion proteins

Publications (2)

Publication Number Publication Date
NO980566L true NO980566L (en) 1998-02-10
NO980566D0 NO980566D0 (en) 1998-02-10

Family

ID=10779307

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980566A NO980566D0 (en) 1995-08-16 1998-02-10 Allergen-XCD32 fusion proteins

Country Status (16)

Country Link
EP (1) EP0846178A1 (en)
JP (1) JPH11513025A (en)
KR (1) KR19990036440A (en)
CN (1) CN1193353A (en)
AU (1) AU6873596A (en)
BR (1) BR9610239A (en)
CA (1) CA2227795A1 (en)
CZ (1) CZ43798A3 (en)
GB (1) GB9516760D0 (en)
HU (1) HUP9802349A3 (en)
IL (1) IL122898A0 (en)
NO (1) NO980566D0 (en)
PL (1) PL324897A1 (en)
SK (1) SK19398A3 (en)
TR (1) TR199800214T1 (en)
WO (1) WO1997007218A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9724531D0 (en) 1997-11-19 1998-01-21 Smithkline Biolog Novel compounds
AU750358B2 (en) 1997-12-02 2002-07-18 Medarex, Inc. Cells expressing anti-Fc receptor binding components
EP1221317A1 (en) * 2000-12-28 2002-07-10 SHAN-Beteiligungsgesellschaft m.b.H. Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins
US8029803B2 (en) 2002-06-20 2011-10-04 Paladin Labs, Inc. Chimeric antigens for eliciting an immune response
US8025873B2 (en) 2002-06-20 2011-09-27 Paladin Labs, Inc. Chimeric antigens for eliciting an immune response
US8007805B2 (en) 2003-08-08 2011-08-30 Paladin Labs, Inc. Chimeric antigens for breaking host tolerance to foreign antigens
BG65715B1 (en) * 2003-09-04 2009-08-31 Чавдар ВАСИЛЕВ Device for selective suppression of pathologic dna-specific b cells
BG65954B1 (en) * 2005-01-05 2010-07-30 Чавдар ВАСИЛЕВ Means for selective suppression of the activity of pathologic autoreactive b-cells
US9636415B2 (en) 2006-03-03 2017-05-02 S-Target Therapeutics Gmbh Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies
EP1829895A1 (en) * 2006-03-03 2007-09-05 f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies
RS61098B1 (en) 2012-06-15 2020-12-31 Immunomic Therapeutics Inc Nucleic acids for treatment of allergies
CN109806388B (en) 2012-07-13 2022-03-08 S-目标疗法有限公司 Immunomodulatory vaccines
AU2013340899B2 (en) * 2012-11-01 2017-10-05 Veterinaerinstituttet New fusion proteins for the treatment of allergic diseases
US9005630B2 (en) 2012-11-01 2015-04-14 Veterinaerinstituttet Fusion proteins for the treatment of allergic diseases
HUE037252T2 (en) 2013-05-21 2018-08-28 Tyg Oncology Ltd Gastrin peptide immunogenic composition
CN113186167B (en) * 2021-04-28 2021-11-30 中国食品药品检定研究院 Method for determining biological activity of anti-CD 20 monoclonal antibody drug ADCP

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994024281A1 (en) * 1993-04-14 1994-10-27 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
AU2670995A (en) * 1994-05-26 1995-12-21 Innogenetics N.V. New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness

Also Published As

Publication number Publication date
KR19990036440A (en) 1999-05-25
EP0846178A1 (en) 1998-06-10
CZ43798A3 (en) 1998-06-17
MX9801253A (en) 1998-05-31
PL324897A1 (en) 1998-06-22
SK19398A3 (en) 1998-09-09
AU6873596A (en) 1997-03-12
NO980566D0 (en) 1998-02-10
CN1193353A (en) 1998-09-16
HUP9802349A2 (en) 1999-01-28
GB9516760D0 (en) 1995-10-18
WO1997007218A1 (en) 1997-02-27
CA2227795A1 (en) 1997-02-27
HUP9802349A3 (en) 1999-04-28
JPH11513025A (en) 1999-11-09
IL122898A0 (en) 1998-08-16
BR9610239A (en) 1999-06-15
TR199800214T1 (en) 1998-06-22

Similar Documents

Publication Publication Date Title
NO980566L (en) Allergen-XCD32 fusion proteins
NO20001508D0 (en) Fusion proteins comprising HIV-1 TAT and / or NEF proteins
NO913524D0 (en) NUCLEOTID SEQUENCE CODING FOR AN OUTER MEMBRANE PROTEIN FRANEISSERIA MENINGITIDIS AND USE THEREOF.
TR199600084A2 (en) Proteins against blistering.
NO950939L (en) Defective adenovirus vectors and their use in gene therapy
ITTO950367A0 (en) RECOMBINANT PRRSV PROTEINS, DIAGNOSTIC KITS AND VACCINES CONTAINING SUCH RECOMBINANT PRRSV PROTEINS.
IL65565A0 (en) Expression of the crystal protein of bacillus thuringiensis in e.coli
DK189090D0 (en) PROTEINS THAT PROMOTE IMMUNOLOGICAL EFFECT CELL ACTIVATION AND CHEMISTRY
NO910388D0 (en) LIGHT OR SIMILAR AND PROCEDURE FOR ITS MANUFACTURING.
FI972384L (en) Novel dipeptide p-amidinobenzylamides containing N-terminal sulfonyl or amidinosulfonyl groups
NO882917L (en) FUSION PROTEINS AND PARTICLES.
DE68907053D1 (en) PRIMER / MEMBRANE SEALING SYSTEM.
DE69714451D1 (en) PRION-BINDING PROTEINS AND THEIR USE
DE3578469D1 (en) ENDOPROTHESIS JOINT COMPONENT FOR TEACHING, RESEARCH AND VIEWING PURPOSES.
NO822796L (en) AMINO ORGANOAMINOSILANES, THE PROCEDURE FOR THEIR PREPARATION AND THEIR USE
BR9709406B1 (en) substituted alkyloxyamino fluorenones and pharmaceutical composition containing them.
NO974811D0 (en) CNS growth modulators, preparations, cells and methods which include and utilize such
IS4987A (en) PTX sensitive G proteins, their production and use
IT1282848B1 (en) LAMINATED OR LAMINATED GLASS AND METHOD FOR ITS MANUFACTURE.
NO167180C (en) TIME-SHARED, MULTIPLEXED ADDRESS AND CONTROL SYSTEM.
NO901758L (en) PURE-INHIBITING DIPEPTIDES, THE PROCEDURE FOR THEIR PREPARATION, MENTALS CONTAINING THESE AND THEIR USE.
ZA9811810B (en) Mammalian circadian regulator m-rigui2 (m-per2).
ITPD940180A0 (en) PROCEDURE FOR LIMITING THE TRANSPARENCY OF FLAT AND/OR CURVED GLASS.
FI893211A0 (en) ANTIHYPERTENSIVE, N-TERMINAL ETHERAMINODIOLAMINO SYRADERIVES.
DK157207C (en) FORWARD FOR CURVED SURFACES, ROUND BUILDINGS AND SIMILAR CONSTRUCTIONS